Patient Guide: Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 17 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06551064
Status: ACTIVE_NOT_RECRUITING
Condition: Melanoma, Stage II, Melanoma Stage III
Phase: PHASE1

Where You Can Participate

This study is available at 17 locations across the country.

Top locations include:
  • • Sarajevo,
  • • Sofia,
  • • Tartu,
  • • And 14 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients - Join Clinical Trial NCTNCT06551064

How to Join This Clinical Trial - NCTNCT06551064

Learn how to participate in this PHASE1 trial studying an investigational therapy for Melanoma, Stage II, Melanoma Stage III. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Melanoma, Stage II, Melanoma Stage III. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Melanoma, Stage II, Melanoma Stage III
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06551064 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 17 locations. Find a study site near you:

Clinical Research Site

Sarajevo, - Bosnia and Herzegovina

Status: Contact for availability

Clinical Research Site

Sofia, - Bulgaria

Status: Contact for availability

Clinical Research Site

Tartu, - Estonia

Status: Contact for availability

Clinical Research Site

Batumi, - Georgia

Status: Contact for availability

Clinical Research Site

Kutaisi, - Georgia

Status: Contact for availability

Clinical Research Site

Tbilisi, - Georgia

Status: Contact for availability

Clinical Research Site

Kaunas, - Lithuania

Status: Contact for availability

Clinical Research Site

Chisinau, - Moldova

Status: Contact for availability

Clinical Research Site

Skopje, - North Macedonia

Status: Contact for availability

Clinical Research Site

Krakow, - Poland

Status: Contact for availability

And 7 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Melanoma, Stage II, Melanoma Stage III:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships